<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016042513691N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-07-25</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effects of  blood sampling place on pain and Physiological indices of premature infants</public_title>
      <acronym></acronym>
      <scientific_title>The comparison of pain and physiological indices in two ways of blood sampling  from  vein hand and vein head in premature infants with gestational age 32-28 weeks</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-04-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/13481</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: pain. Condition 2: Blood-sampling.</hc_freetext>
      <i_freetext>Intervention 1: Eligible infants who need for venous sampling in fourth to eighth days of their birth will be entered to study with convenience sampling method and recruited into two groups randomly. In the first group, first blood sampling through the vein of hand (Cephalic and Basilic veins and dorsal venous plexus back of the hand), the next day blood sampling through the vein of head (Superficial temporal vein in the side of the head and supratrochlear vein in the frontal part of the skull) will be use. For blood sampling from the vein of head, head circumference at the upper part of the eyebrows will be closed with a soft rubber band (Coban) with 1.5 cm of diameter, and for taking blood from the vein of the back of the hand, restriction will be performed via colleague’s hand. Blood sampling will be carried out in direction of blood flow using Bio.Flon IV (No#24) with angle of 15 to 20 degrees in head vein and 25 to 45 degrees in hand vein. Trying to sampling will not be more than once. Pain score will be measured using pain scale. To investigate the physiological indices, a monitor device will be attached to the baby's foot, and heart rate and percentage of arterial oxygen saturation, will be monitored throughout the study. In this study, to record the behavioral and physiological responses to pain two recording devices will be used. One of recording devices will be fixed to monitor to record the pyisiological responses and the next recording device will be focused the baby’s face and limbs to record its behavioral responses. Intervention 2: In Newborns of second group, blood sampling will be reversely; in which the first blood sampling will be done through the veins of head(Superficial temporal vein in the side of the head and supratrochlear vein in the frontal part of the skull), and the further blood sampling will be done through hand veins (Cephalic and Basilic veins and dorsal venous plexus back of the hand), in next day. For blood sampling from the vein of head, head circumference at the upper part of the eyebrows will be closed with a soft rubber band (Coban) with 1.5 cm of diameter, and for taking blood from the vein of the back of the hand, restriction will be performed via colleague’s hand. Blood sampling will be carried out in direction of blood flow using Bio.Flon IV (No#24) with angle of 15 to 20 degrees in head vein and 25 to 45 degrees in hand vein. Trying to sampling will not be more than once. Pain score will be measured using pain scale. To investigate the physiological indices, a monitor device will be attached to the baby's foot, and heart rate and percentage of arterial oxygen saturation, will be monitored throughout the study. In this study, to record the behavioral and physiological responses to pain two recording devices will be used. One of recording devices will be fixed to monitor to record the pyisiological responses and the next recording device will be focused the baby’s face and limbs to record its behavioral responses.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname></firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address></address>
        <city></city>
        <country1></country1>
        <zip></zip>
        <telephone></telephone>
        <email></email>
        <affiliation></affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arshadi Bostanabad Mohammad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Sharyati Ave-Nursing and Midwifery Faculty</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>arshadi@tbzmed.ac.irarshadi-m@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: gestational age of 28-30 weeks and 30-32 weeks and appropriate weight for gestational age; need for venous blood sampling in 4 to 8 days after birth; absence of congenital malformations and skin lesions on infants’ hands or heads; the absence of blood disorders in mother's medical history; no history of smoking, alcohol and drug consumption by mothers during pregnancy; not using of sedative from 12 hours before sampling; absence of Signs of Asphyxia; Stability of cardio-respiratory status; The intervals between two sampling times more than 24 hours; not receiving invasive interventions in the last six hours before blood sampling.&#13;
Exclusion criteria: Parents’ willing to study; multiple try for sampling; report of cerebral hemorrhage or brain abnormalities in cranial ultrasound; inappropriate quality of video to interpretation.</inclusion_criteria>
      <agemin>4 days</agemin>
      <agemax>8 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M79.8</hc_code>
      <hc_code>Y84.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other specified soft tissue disorders</hc_keyword>
      <hc_keyword>Medical procedure, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Eligible infants who need for venous sampling in fourth to eighth days of their birth will be entered to study with convenience sampling method and recruited into two groups randomly. In the first group, first blood sampling through the vein of hand (Cephalic and Basilic veins and dorsal venous plexus back of the hand), the next day blood sampling through the vein of head (Superficial temporal vein in the side of the head and supratrochlear vein in the frontal part of the skull) will be use. For blood sampling from the vein of head, head circumference at the upper part of the eyebrows will be closed with a soft rubber band (Coban) with 1.5 cm of diameter, and for taking blood from the vein of the back of the hand, restriction will be performed via colleague’s hand. Blood sampling will be carried out in direction of blood flow using Bio.Flon IV (No#24) with angle of 15 to 20 degrees in head vein and 25 to 45 degrees in hand vein. Trying to sampling will not be more than once. Pain score will be measured using pain scale. To investigate the physiological indices, a monitor device will be attached to the baby's foot, and heart rate and percentage of arterial oxygen saturation, will be monitored throughout the study. In this study, to record the behavioral and physiological responses to pain two recording devices will be used. One of recording devices will be fixed to monitor to record the pyisiological responses and the next recording device will be focused the baby’s face and limbs to record its behavioral responses.</i_keyword>
      <i_keyword>In Newborns of second group, blood sampling will be reversely; in which the first blood sampling will be done through the veins of head(Superficial temporal vein in the side of the head and supratrochlear vein in the frontal part of the skull), and the further blood sampling will be done through hand veins (Cephalic and Basilic veins and dorsal venous plexus back of the hand), in next day. For blood sampling from the vein of head, head circumference at the upper part of the eyebrows will be closed with a soft rubber band (Coban) with 1.5 cm of diameter, and for taking blood from the vein of the back of the hand, restriction will be performed via colleague’s hand. Blood sampling will be carried out in direction of blood flow using Bio.Flon IV (No#24) with angle of 15 to 20 degrees in head vein and 25 to 45 degrees in hand vein. Trying to sampling will not be more than once. Pain score will be measured using pain scale. To investigate the physiological indices, a monitor device will be attached to the baby's foot, and heart rate and percentage of arterial oxygen saturation, will be monitored throughout the study. In this study, to record the behavioral and physiological responses to pain two recording devices will be used. One of recording devices will be fixed to monitor to record the pyisiological responses and the next recording device will be focused the baby’s face and limbs to record its behavioral responses.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: from 2 minutes to 6 minutes after blood sampling, Every 2 minutes. Method of measurement: Astrid Lindgren Children’s Hospital Pain Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart rate , Blood oxygen saturation. Timepoint: from 2 minutes to 6 minutes after blood sampling, Every 2 minutes. Method of measurement: monitor device - Massimo 1600.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-05-09</approval_date>
        <contact_name>Tabriz University of Medical Sciences</contact_name>
        <contact_address>South Sharyati Ave.-Nursing and Midwifery Faculty Tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
